![ES-D3 [D3]](/static/images/cells-no_picture.jpg)
-
平臺(tái)編號(hào)：bio-68679
-
國(guó)際編號(hào)：CRL-11632?
-
細(xì)胞信息： ES-D3 [D3]
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類(lèi)或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
ES-D3 [D3]
細(xì)胞形態(tài)：其他
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
年限：embryo, blastocyst
運(yùn)輸方式：凍存運(yùn)輸
品系：129S2/SvPas
細(xì)胞類(lèi)型：其他細(xì)胞類(lèi)型
數(shù)量：大量
是否是腫瘤細(xì)胞：0
物種來(lái)源：小鼠
ATCC Number：CRL-11632?
器官來(lái)源：胚胎
規(guī)格：10ml Designations: ES-D3 [D3]
Depositors: ?P Chambon
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Mus musculus
Morphology:spherical colonies
Source: Organ: embryo
Strain: 129S2/SvPas
Cell Type: pluripotent embryonic stem cell;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: embryo, blastocyst
Comments:The cells spontaneously differentiate into embryonic structures in the absence of a feeder layer or conditioned medium. They can be injected back into blastocysts and contribute to the germline. Undifferentiated cells can be genetically modified by gene targeting techniques.
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose supplemented with 0.1 mM 2-mercaptoethanol, 85%; heat-inactivated fetal bovine serum, 15%
Temperature: 37.0°C
Subculturing: Protocol: Note: The cells can be maintained in the undifferentiated state by frequent subculture on feeder layers of irradiated (3000 rads) or mitomycin C treated (0.01 mg/ml for 90 minutes) primary mouse embryonic fibroblasts or STO cells (see ATCC CRL-1503 , STO or ATCC 56-X, irradiated STO cells).
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
feeder layer cells:ATCC 56-X
References: 22394: Doetschman TC, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87: 27-45, 1985. PubMed: 3897439
22928: Williams RL, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687, 1988. PubMed: 3143916
23296: Gossler A, et al. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83: 9065-9069, 1986. PubMed: 3024164
23307: Doetschman T, et al. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 85: 8583-8587, 1988. PubMed: 3186749
70349: Chambon P, et al. Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins. US Patent 6,486,381 dated Nov 26 2002
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
年限：embryo, blastocyst
運(yùn)輸方式：凍存運(yùn)輸
品系：129S2/SvPas
細(xì)胞類(lèi)型：其他細(xì)胞類(lèi)型
數(shù)量：大量
是否是腫瘤細(xì)胞：0
物種來(lái)源：小鼠
ATCC Number：CRL-11632?
器官來(lái)源：胚胎
規(guī)格：10ml Designations: ES-D3 [D3]
Depositors: ?P Chambon
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Mus musculus
Morphology:spherical colonies
Source: Organ: embryo
Strain: 129S2/SvPas
Cell Type: pluripotent embryonic stem cell;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: embryo, blastocyst
Comments:The cells spontaneously differentiate into embryonic structures in the absence of a feeder layer or conditioned medium. They can be injected back into blastocysts and contribute to the germline. Undifferentiated cells can be genetically modified by gene targeting techniques.
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose supplemented with 0.1 mM 2-mercaptoethanol, 85%; heat-inactivated fetal bovine serum, 15%
Temperature: 37.0°C
Subculturing: Protocol: Note: The cells can be maintained in the undifferentiated state by frequent subculture on feeder layers of irradiated (3000 rads) or mitomycin C treated (0.01 mg/ml for 90 minutes) primary mouse embryonic fibroblasts or STO cells (see ATCC CRL-1503 , STO or ATCC 56-X, irradiated STO cells).
- Remove and discard culture medium.
- Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
-
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37?C to facilitate dispersal. - Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
- Add fresh medium, aspirate and dispense onto fresh feeder layer cultures.
-
Incubate cultures at 37?C.
Subcultivation Ratio: A subcultivation ratio of 1:4 is recommended
Medium Renewal: Every 2 to 3 days
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
feeder layer cells:ATCC 56-X
References: 22394: Doetschman TC, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87: 27-45, 1985. PubMed: 3897439
22928: Williams RL, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687, 1988. PubMed: 3143916
23296: Gossler A, et al. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83: 9065-9069, 1986. PubMed: 3024164
23307: Doetschman T, et al. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 85: 8583-8587, 1988. PubMed: 3186749
70349: Chambon P, et al. Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins. US Patent 6,486,381 dated Nov 26 2002
